Crossmark

Therapeutic potency of a developed optimized polyherbal formulation in ameliorating obesity induced inflammation and oxidative stress in Swiss albino mice by targeting PPARγ, insulin receptor and AMPK signalling pathway

Crossref DOI link: https://doi.org/10.1007/s10822-025-00625-0

Published Online: 2025-07-14

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Das, Pritimoni

Das, Manas
Funding

Funding for this research was provided by:

No funding
License Information

Text and Data Mining valid from 2025-07-14

Version of Record valid from 2025-07-14
More Information

Article History

Received: 5 April 2025

Accepted: 26 June 2025

First Online: 14 July 2025

Change Date: 2 August 2025

Change Type: Update

Change Details: minor correction in affiliation

Declarations

:

: The authors declare no competing interests.

: The animals were handled following the standard ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines with the permission from Institutional Animal Ethical Committee (IAEC Reference no: IAEC/Cer/2019/RF/2019-4).

Document is current

Any future updates will be listed below